Gilead Sciences

Mentioned in 9 analyzed podcast episodes across 8 shows

Mentioned On

硅谷101 Pharma and BioTech Daily The a16z Show The Compound and Friends Drink Champs CNBC's "Fast Money"The Interview This Week in Virology

Episode Mentions

硅谷101 · May 9, 2026

E235｜CAR-T能治愈癌症吗？与刘诚博士聊聊CAR-T与癌症治疗的未来

“Acquired Kite Pharma; major player in commercialized CAR-T therapies for blood cancers”

CAR-T cell therapy mechanism and design principlesEx vivo vs. in vivo CAR-T manufacturing and cost comparisonCAR-T efficacy in blood cancers (lymphoma, leukemia, multiple myeloma)

View Analysis

Pharma and BioTech Daily · May 7, 2026

Bayer's $2.4B Perfuse Deal Shakes Up Eye Care | Pharma and Biotech Daily

“Acquired Arcelex for CAR-T cell therapy and announced workforce reductions following acquisition integration”

Ophthalmology Portfolio ExpansionAI-Driven Drug Development CommercializationGLP-1 Agonist Obesity Treatment Competition

View Analysis

The a16z Show · Apr 29, 2026

The Shift in Global Drug Development

“Referenced for hepatitis C cure development and subsequent competitive copying by other manufacturers”

Clinical Trial Regulatory ReformDrug Approval Timelines and FDA ProcessGene Therapy and Cell Therapy Development

View Analysis

Pharma and BioTech Daily · Apr 29, 2026

AstraZeneca's Breztri Asthma Approval Boosts $80B Goal | Pharma and Biotech Daily

“Parent company of Kite Pharma, advancing CAR-T cell therapy for hematologic malignancies”

FDA Drug Approval and RescissionData Integrity in Drug DevelopmentAI-Designed Therapeutics

View Analysis

The Compound and Friends · Apr 24, 2026

Why Nvidia is Going to 10 Trillion Dollars with Adam Parker⁠ and ⁠Rob Sechan

“Healthcare company; dominant in HIV, advancing in oncology; 50 drugs in development; quality healthcare play”

Software sector earnings misses and margin compressionSemiconductor valuation and earnings estimate revisionsAI productivity impact on enterprise profitability

View Analysis

Drink Champs · Apr 15, 2026

#Throwback Episode - w/ Onyx | (Ep.83 & 84)

“Pharmaceutical sponsor of HIV awareness segment 'Care for the Culture' featured in episode”

Hip-hop artist development and mentorship modelsTransition from music to film and television actingInternational touring and global hip-hop markets

View Analysis

CNBC's "Fast Money" · Feb 25, 2026

All Eyes on Nvidia’s Latest Quarter… And Housing and Retail Flash Warning Signs 2/25/26

“Stock up 30% past year; Chief Commercial Officer Joanna Mercier recognized as CNBC Changemaker for HIV prevention injectable launch”

NVIDIA Q4 Earnings and Q1 GuidanceData Center Revenue Growth and MarginsAI Hardware vs. Software Valuation Divergence

View Analysis

The Interview · Feb 9, 2026

Dr Aaron Motsoaledi, South African health minister: The fight against HIV/AIDS continues.

“Manufactures Lenacapavir, the expensive HIV prevention drug being negotiated for lower-cost distribution in South Africa”

US Foreign Aid Withdrawal and PEPFAR Funding CutsHIV/AIDS Treatment Scale-Up and ARV DistributionUniversal Health Coverage (National Health Insurance - NHI)

View Analysis

This Week in Virology · Jan 31, 2026

TWiV 1292: Clinical update with Dr. Daniel Griffin

“Manufacturer of Paxlovid (nirmatrelvir/ritonavir), COVID-19 antiviral showing 42% reduction in intubation/mortality”

WHO Withdrawal and Global Health GovernanceVaccine Hesitancy and Immunization PolicyMeasles Resurgence and Elimination Status

View Analysis